Claes Hilde DR. SRL
Claes Hilde DR. reported total assets of 670,071 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jan 2026).
The score of Claes Hilde DR. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +11 % Total assets +8 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Claes Hilde DR.'s annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 69,553 € | ||||
| Equity | 638,803 € | ||||
| Cash | 611,906 € | ||||
| EBITDA | 104,554 € | ||||
| Total assets | 670,071 € |
Filed annual accounts
- Year ended 31 Jul 2025filed on 30 Jan 2026
- Year ended 31 Jul 2024filed on 04 Feb 2025
- Year ended 31 Jul 2023filed on 22 Feb 2024
- Year ended 31 Jul 2022filed on 10 Feb 2023
- Year ended 31 Jul 2021filed on 21 Feb 2022
Claes Hilde DR.'s financial analysis
- Solvency95.3%sector median: 72.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Claes Hilde DR.
Claes Hilde DR.'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0829.120.465
- VAT number
- BE0829120465
- Peppol
- Registered · 0208:0829120465 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Sep 2010
- Registered office
- 2960 Brecht
- Latest accounts
- 2025 · filed on 30 Jan 2026
- Activity
- General medical practice activities (NACE 86210)
Claes Hilde DR. (SRL) has been based in Brecht since 2010, active in: general medical practice activities. For 2025, it reports a net profit of 69,553 € and equity of 638,803 €; its revenue is not published. Its solvency stands at 95.3%, above the median of its sector (72.4%).
Companies similar to Claes Hilde DR.
Companies in the same business, of comparable size and area, outside its group.
- Kumeco Business and other management consultancy activities Ranst · balance sheet 670,155 €
- GAM Television programming, broadcasting and video distribution activities Waimes · balance sheet 670,239 €
- Verhavert Activities of agents involved in the wholesale of food, beverages and tobacco Antwerp · balance sheet €1.15m
- Magma Nova Manufacture of flat glass Molenbeek-Saint-Jean · balance sheet 669,676 €
- Property and Partner Brussels · balance sheet 669,590 €
- ATV Invest Group LOG Buying and selling of own real estate Zandhoven · balance sheet 670,918 €
- Immo GTT Rental and operating of own or leased real estate Zandhoven · balance sheet 670,923 €
- Societe Medicale Buonomo Honnelles · balance sheet 669,821 €
Frequently asked questions about Claes Hilde DR.
What is the revenue of Claes Hilde DR.?
Claes Hilde DR. files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Claes Hilde DR.?
In Belgium, the VAT number is the company number prefixed with BE: BE0829120465 for Claes Hilde DR., if the company is VAT-registered. Its company number (CBE) is 0829.120.465.
Where is the registered office of Claes Hilde DR.?
According to the CBE register, the registered office of Claes Hilde DR. is in 2960 Brecht.
What is the equity of Claes Hilde DR.?
At the close of the 2025 financial year, the equity of Claes Hilde DR. amounts to 638,803 €, a solvency of 95.3% of total assets.
Who manages Claes Hilde DR.?
The register lists 1 active mandates at Claes Hilde DR.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Claes Hilde DR.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →